000
| 01087nam##2200253za#4500 |
---|
001 | 9.686614 |
---|
003 | CaOODSP |
---|
005 | 20210624230621 |
---|
007 | cr ||||||||||| |
---|
008 | 150407|2003||||xxc|||||o f|0| 0 eng|d |
---|
020 | |a0-662-34662-9 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/94-2003E-PDF |
---|
110 | 1 |aCanada. |bHealth Products and Food Branch. |
---|
245 | 10|aImpurities in new drug products - ICH topic Q3B(R) : |h[electronic resource]|bguidance for industry |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |cSeptember 25, 2003. |
---|
300 | |a19p.|bfig., glossary, graph, table |
---|
500 | |aThe catalogue number (H42-2/94-2003E) and ISBN (0-662-34661-0) for the print edition have been incorrectly copied in this PDF edition. |
---|
590 | |a07-02-Supp|b2007-04-05 |
---|
690 | 07|aHealth|2gcpds |
---|
690 | 07|aPrescription drugs|2gcpds |
---|
775 | 08|tPrésence d'impuretés dans les nouveaux produits - ICH thème Q3B(R) : |w(CaOODSP)9.631080 |
---|
856 | 40|ahttp://publications.gc.ca|qPDF|s62 KB|uhttps://publications.gc.ca/collections/Collection/H42-2-94-2003E.pdf |
---|